Characteristic | All Patients (n = 388) | HFNC Success Group (n = 256) | HFNC Failure Group (n = 132) | p |
---|---|---|---|---|
Age (years, mean ± SD) | 67.97 ± 14.40 | 66.84 ± 13.83 | 70.15 ± 15.44 | 0.286 |
Gender | ||||
 Male (n, %) | 284, 73.20% | 188, 73.43% | 96, 72.73% | 0.941 |
 Female (n, %) | 104, 26.80% | 68, 26.57% | 36, 27.27% |  |
Comorbidities and risk factors | ||||
 Hypertension (n, %) | 244, 62.89% | 168, 65.63% | 76, 57.58% | 0.442 |
 Chronic Cardiac disease (n, %) | 116, 27.84% | 56, 21.88% | 20, 15.15% | 0.474 |
 Diabetes mellitus (n, %) | 120, 30.93% | 80, 31.25% | 40, 30.30% | 0.925 |
 COPD (n, %) | 20, 0.52% | 12, 4.69% | 8, 6.06% | 0.775 |
 Emphysema(n, %) | 20, 0.52% | 8, 3.13% | 8, 6.06% | 0.236 |
 Current smoker | 44, 11.34% | 28, 10.94% | 16, 12.12% | 0.863 |
 COVID 19 | 200, 51.55% | 136, 53.13% | 64, 48.48% | 0.669 |
 Time since symptom onset (d) | 14.25 ± 13.22 | 13.13 ± 11.17 | 16.42 ± 16.47 | 0.246 |
 Whether the host is immunosuppressed (n, %) | 27, 27.84% | 14, 21.88% | 13, 39.39% | 0.069 |
 ROX index | 5.9487 ± 2.6762 | 6.5779 ± 2.8139 | 6.5779 ± 2.8139 | 0.001 |
PSI score | Â | Â | Â | 0.001 |
 I (n, %) | 3(3.09%) | 3(4.69%) | 0 |  |
 II (n, %) | 10(10.31%) | 9(14.06%) | 1(3.03%) |  |
 III (n, %) | 25(25.77) | 20(31.25%) | 5(15.15%) |  |
 IV (n, %) | 38(39.18%) | 23(35.94%) | 15(45.45%) |  |
 V (n, %) | 21(21.65%) | 9(14.06%) | 12(36.36%) |  |
 CURB-65 | 1.577 ± 0.945 | 1.422 ± 0.956 | 1.879 ± 0.857 | 0.023 |
 CPIS Score | 1.879 ± 0.857 | 4.578 ± 1.434 | 5.242 ± 1.480 | 0.035 |
CT score | ||||
 0 h CT score | 12.28 ± 4.132 | 11.52 ± 4.136 | 13.81 ± 3.736 | 0.011 |
 1 week CT score | 11.53 ± 4.795 | 11.27 ± 5.196 | 11.96 ± 4.118 | 0.574 |
 APACHE II score | 13.64 ± 6.327 | 12.71 ± 6.474 | 15.18 ± 5.844 | 0.076 |
 SOFA score | 4.614 ± 2.826 | 3.946 ± 2.383 | 5.727 ± 3.175 | 0.004 |
 Glucocorticoid (n, %) | 80, 82.47% | 51, 79.69% | 29, 87.88% | 0.32 |